Results 161 to 170 of about 5,561 (172)

The long-term efficacy and tolerability of oral deferasirox for patients with transfusion-dependent β-thalassemia in Taiwan

Annals of Hematology, 2015
Hsiu-Hao Chang, Meng-Yao Lu, Steven Shinn-Forng Peng   +2 more
exaly  

Hyperchloraemic metabolic acidosis induced by the iron chelator deferasirox: a case report and review of the literature

Journal of Clinical Pharmacy and Therapeutics, 2013
M G Bianchetti
exaly  

Efficacy and safety of deferasirox doses of >30 mg/kg per d in patients with transfusion‐dependent anaemia and iron overload

British Journal of Haematology, 2009
Ali T Taher, Maria Domenica Cappellini, Elliott Vichinsky   +2 more
exaly  

Reduction in labile plasma iron during treatment with deferasirox, a once‐daily oral iron chelator, in heavily iron‐overloaded patients with β‐thalassaemia

European Journal of Haematology, 2009
Shahina Daar, Anil Pathare, Hanspeter Nick   +2 more
exaly  

A simple LC–MS/MS method for determination of deferasirox in human plasma: Troubleshooting of interference from ferric ion in method development and its application

Journal of Pharmaceutical and Biomedical Analysis, 2018
Tengfei Li, Zhiming Cui, Wen Yang
exaly  

Deferasirox at therapeutic doses is associated with dose-dependent hypercalciuria

Bone, 2016
Phillip Wong, Kevan R Polkinghorne, Peter G Kerr   +2 more
exaly  

Deferasirox

Reactions Weekly, 2011
openaire   +1 more source

Adherence to iron chelation therapy in patients who switched from deferasirox dispersible tablets to deferasirox film-coated tablets

Current Medical Research and Opinion, 2018
Wendy Y Cheng, Qayyim Said, Yanni Hao
exaly  

Terbium‐sensitized fluorescence method for the determination of deferasirox in biological fluids and tablet formulation

Luminescence, 2011
Jamshid L Manzoori, Abolghasem Jouyban, Mohammad Amjadi   +2 more
exaly  

Synthesis and Characterization of Related Substances of Deferasirox, an Iron (Fe3+) Chelating Agent

Synthetic Communications, 2012
exaly